Scabies mite intestinal proteases as targets for novel therapeutics. [ 2014 - 2017 ]

Research Grant

Researchers: Dr Katja Fischer (Principal investigator) ,  Dr Deborah Holt ,  Dr Simone Reynolds ,  Prof Ben Dunn ,  Prof Robert Pike

Brief description Scabies causes bacterial disease affecting poor people worldwide. Available therapies are limited and drug resistance is emerging. We investigate molecules that the mite needs to infest the skin, to guide the formulation and the testing of novel drugs. This will provide improved treatment of affected individuals and their families, thereby reducing the spread of scabies and bacterial infections and their devastating sequelae, particularly in Australian Indigenous communities.

Funding Amount $AUD 672,533.26

Funding Scheme Project Grants

Notes Standard Project Grant